Protocol 63623872FLZ3002: A Phase 3 Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, and Elderly Non-hospitalized

Project: Other project

StatusActive
Effective start/end date2/5/1812/31/19

Funding

  • Janssen Pharmaceutica NV: $5,946.00